LINC00052 upregulates EPB41L3 to inhibit migration and invasion of hepatocellular carcinoma by binding miR-452-5p

MLA

Yuyang Liu, et al. “LINC00052 Upregulates EPB41L3 to Inhibit Migration and Invasion of Hepatocellular Carcinoma by Binding MiR-452-5p.” Oncotarget, vol. 8, no. 38, Mar. 2017. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....8cdf3409795b782b822b084172282cbb&authtype=sso&custid=ns315887.

APA

Yuyang Liu, Liying Zhu, Wei Pan, Xing Li, Guiqin Du, Gangfeng Yu, Juan Chen, Qiuxu Chen, Hua Tang, Huihao Zhou, Tao Zeng, Nenghong Yang, Shaoying Yan, & Ailong Huang. (2017). LINC00052 upregulates EPB41L3 to inhibit migration and invasion of hepatocellular carcinoma by binding miR-452-5p. Oncotarget, 8(38).

Chicago

Yuyang Liu, Liying Zhu, Wei Pan, Xing Li, Guiqin Du, Gangfeng Yu, Juan Chen, et al. 2017. “LINC00052 Upregulates EPB41L3 to Inhibit Migration and Invasion of Hepatocellular Carcinoma by Binding MiR-452-5p.” Oncotarget 8 (38). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....8cdf3409795b782b822b084172282cbb&authtype=sso&custid=ns315887.